Por: CNBC Health March 16, 2023
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, January 9, 2020.George Frey Reuters on Thursday said it's planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket costs at $35 for people who have private insurance starting next year. In addition to its widely prescribed Lantus, the French drugmaker will reduce the list price of... + full article
Forbes USA Business March 17, 2023
Topline Pharmaceutical giant Sanofi announced Thursday it will cut the price of its most commonly prescribed insulin by 78% and cap the monthly cost at $35, becoming the latest drug maker—behind Eli Lilly and Novo Nordisk—to slash insulin costs this month, amid growing calls... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
How the Other Insulin Makers Are Responding to Eli Lilly’s Price Cap | Time
ABC7 USA Health March 17, 2023
Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.The move follows similar ones by Eli Lilly and... + más
Sanofi is the latest insulin maker to announce price cap | WPTV
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk | Forbes
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
Fox Business USA Business March 14, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues there will be 'great growth' in the pharmaceutical industry. Pharmaceutical giant Novo Nordisk will lower the cost of several of its by up to 75% next year. Effective January 2024, the list price for insulin... + más
Time USA Health March 03, 2023
Facing pressure to curb diabetes-treatment costs, Eli Lilly & Co. announced on March 1 that it is slashing insulin prices and immediately capping the out-of-pocket cost of all of its insulins at $35 a month. President Joe Biden, who made insulin costs a last month, praised the... + más
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions | NBC News
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
Orlando Sentinel USA Business March 01, 2023
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000... + más
Portland Press Herald USA World March 01, 2023
Eli Lilly plans to slash some insulin prices, expand cost cap | Orlando Sentinel
About iurex | Privacy Policy | Disclaimer |